Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
1
0
0
1
The addition of savolitinib to standard chemotherapy and a VEGF inhibitor may have contributed additional antitumor activity in this patient with MET-amplified mCRC, suggesting a possible additive contribution of MET inhibition.